Related Topics:
Facility ID: 90505BCHMN3132K
Facility Name and Address: BACHEM AMERICAS INC. 3132 KASHIWA ST TORRANCE, CA 90505 Parent Company: NA Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: N,N-Dimethylformamide Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000068122
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2019 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B5 - Specific regulatory/permit burdens. - The current process is approved by our customers and regulated by the FDA. Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The current process is approved by our customers and regulated by the FDA. |
|
2018 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B5 - Specific regulatory/permit burdens. - The current process is approved by our customers and regulated by the FDA. Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The current process is approved by our customers and regulated by the FDA. |
|
2017 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The current process is approved and regulated by the FDA. Barriers to P2: B5 - Specific regulatory/permit burdens. - The current process is approved and regulated by the FDA. |
|
2016 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The current process is approved and regulated by the FDA. Barriers to P2: B5 - Specific regulatory/permit burdens. - The current process is approved and regulated by the FDA. |
|
2015 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The current process is approved and regulated by the FDA. Barriers to P2: B5 - Specific regulatory/permit burdens. - The current process is approved and regulated by the FDA. |
|
2014 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - due to the fact that Bachem Americas, Inc. is regulated by the FDA. |
|
2013 |
Other Barriers to Source Reduction - Concern that product quality may decline as a result of source reduction and specific regulatory/permit burdens due to the fact that Bachem is regulated by the FDA. |
||
2012 |
Other Barriers to Source Reduction - Concern that product quality may decline as a result of source reduction and Specific regulatory/permit burdens due to fact that Bachem is regulated by the FDA |
||
2011 | Barriers to P2 - Bachem is regulated by the FDA. | ||
2009 | Barriers to P2 - This facility is regulated by the food and drug admininstration (Fda). Any changes in process activities including source reduction and recycling must be approved in advance by the fda. | ||
2008 | Barriers to P2 - This facility is regulated by the food and drug admininstration (Fda). Any changes in process activities including source reduction and recycling must be approved in advance by the fda. | ||
2001 |
Source Reduction:: W13: Improved maintenance scheduling, recordkeeping, or procedures
Source Reduction:: W19: Other changes in operating practices Source Reduction:: W58: Other process modifications |
Methods to Identify SR Opportunities: T03: Materials balance audits
Methods to Identify SR Opportunities: T04: Participative team management Methods to Identify SR Opportunities: T03: Materials balance audits Methods to Identify SR Opportunities: T04: Participative team management Methods to Identify SR Opportunities: T04: Participative team management |
|
2000 |
Source Reduction:: W19: Other changes in operating practices
|
Methods to Identify SR Opportunities: T04: Participative team management
|